Riding a wave to better medical diagnosis

This imaging is beneficial for health-care professionals to make correct diagnoses, but the added insight of spectroscopy provides even more detail. Spectroscopy offers a means to identify biomolecules within specimens through their characteristic signatures for absorption in the electromagnetic spectrum.

Now, researchers at UBC Okanagan's School of Engineering want to take that diagnostic imaging a step further.

By recognizing the benefits of imaging and spectroscopy, the researchers in UBCO's Integrated Optics Laboratory (IOL) are now developing imaging systems that apply terahertz radiation. Terahertz radiation lies in the electromagnetic spectrum, with frequencies between radio and visible waves. This opens the door to fast and accurate terahertz characterizations of biological specimens -- and can ultimately help with the creation of effective technologies for cancer detection.

"By working with terahertz radiation, we're able to glean details on the underlying characteristics of biological specimens," explains Alexis Guidi, a School of Engineering master's student and lead author of a new study published in Scientific Reports. "This insight comes from the nature of terahertz radiation, which is intricately sensitive to the biomolecular make-up of cells."

Nonetheless, according to Dr. Jonathan Holzman, IOL Principal Investigator and Electrical Engineering Professor, there are pressing challenges in developing these terahertz systems.

"The characteristics of terahertz radiation that make it an effective probe of biomolecules, in terms of its long wavelengths, also make it challenging to focus and resolve in images. Our recent work solved this by demonstrating terahertz spectroscopy can show a resolution approaching the cellular scale."

The researchers plan on applying their findings in emerging areas of medical diagnoses, with a particular emphasis on carcinogenesis -- the process by which healthy cells become cancerous.

The research is partially funded through support from the Natural Sciences and Engineering Research Council of Canada, the Canada Foundation for Innovation and Western Economic Diversification Canada.

--Source:University of British Columbia Okanagan campus--

 By leveraging cutting-edge AI and IoT technology, VinBrain has successfully has been deployed in over 100 hospitals in Vietnam, Myanmar, New Zealand, India and the U.S. Our platforms are being used by thousands of doctors daily, leading to improved outcomes for more than 2 million patients and becoming The FIRST & ONLY AI Product for X-ray Diagnostics in Vietnam and Southeast Asia that meets US FDA standards.  

Check out our flagship products: 
- DrAid™ CXR Screening - A new age solution in triage and notification for comprehensive chest screening, powered by AI, for 52 abnormalities detection with 91% accuracy. 
- DrAid™ CT Liver Cancer - An AI-powered platform designed to assist radiologists in automatically detecting abnormal lesions in the liver through CT imaging, provide clinical solutions to aid in the early identification of liver cancer, as well as assist oncologists in developing treatment plans. 
- DrAid™ Enterprise Data - The Innovative AI Platform for Healthcare Digital Transformation